[go: up one dir, main page]

MX9205851A - Compuestos quimicos - Google Patents

Compuestos quimicos

Info

Publication number
MX9205851A
MX9205851A MX9205851A MX9205851A MX9205851A MX 9205851 A MX9205851 A MX 9205851A MX 9205851 A MX9205851 A MX 9205851A MX 9205851 A MX9205851 A MX 9205851A MX 9205851 A MX9205851 A MX 9205851A
Authority
MX
Mexico
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
MX9205851A
Other languages
English (en)
Inventor
Roderick Alan Porter
Hunter Douglas Prain
Kenneth John Murray
Brian Herbert Warrington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9205851A publication Critical patent/MX9205851A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
MX9205851A 1991-10-11 1992-10-09 Compuestos quimicos MX9205851A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919121651A GB9121651D0 (en) 1991-10-11 1991-10-11 Chemical compounds

Publications (1)

Publication Number Publication Date
MX9205851A true MX9205851A (es) 1993-06-01

Family

ID=10702801

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205851A MX9205851A (es) 1991-10-11 1992-10-09 Compuestos quimicos

Country Status (9)

Country Link
EP (1) EP0607217A1 (es)
JP (1) JPH07500102A (es)
AU (1) AU654051B2 (es)
CA (1) CA2120756A1 (es)
GB (1) GB9121651D0 (es)
MX (1) MX9205851A (es)
PT (1) PT100949A (es)
WO (1) WO1993007137A1 (es)
ZA (1) ZA927786B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323916A1 (de) * 1993-07-16 1995-01-19 Basf Ag Substituierte 2-Phenylpyridine
DE102004050196A1 (de) 2004-10-15 2006-04-20 Sanofi-Aventis Deutschland Gmbh Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
CN101602687A (zh) * 2008-06-13 2009-12-16 上海特化医药科技有限公司 6-硝基苯乙酮类化合物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809481D0 (en) * 1988-04-21 1988-05-25 Smith Kline French Lab Chemical compounds
GB8923131D0 (en) * 1989-10-13 1989-11-29 Smith Kline French Lab Chemical compounds
EP0532531A1 (en) * 1990-05-21 1993-03-24 Smith Kline & French Laboratories Limited Phenol and pyridinol derivatives as pharmaceuticals

Also Published As

Publication number Publication date
ZA927786B (en) 1994-04-11
AU654051B2 (en) 1994-10-20
JPH07500102A (ja) 1995-01-05
AU2693392A (en) 1993-05-03
CA2120756A1 (en) 1993-04-15
PT100949A (pt) 1994-06-30
WO1993007137A1 (en) 1993-04-15
EP0607217A1 (en) 1994-07-27
GB9121651D0 (en) 1991-11-27

Similar Documents

Publication Publication Date Title
FI922424A7 (fi) Kemiallisia yhdisteitä
MX9101375A (es) Compuestos quimicos
FI944078A7 (fi) Kemiallisia yhdisteitä
FI893751A7 (fi) Kemialliset yhdisteet
FI955587A7 (fi) Kemialliset yhdisteet
FI941574L (fi) Kemiallisia yhdisteitä
FI930773A7 (fi) En kemisk process
FI911286A7 (fi) Kemialliset yhdisteet
FI894648A7 (fi) Kemiallisia yhdisteitä
MX9202262A (es) Compuestos quimicos.
FI922423A7 (fi) Kemiallisia yhdisteitä
FI945907A0 (fi) Kemiallisia yhdisteitä
FI922170L (fi) Kemisk process
FI923757L (fi) Kemisk process
FI910059A7 (fi) Kemialliset yhdisteet
FI925259L (fi) Kemiskt foerfarande
NO930791D0 (no) Substituerte tinnsilikatforbindelser
MX9205851A (es) Compuestos quimicos
FI920668L (fi) Oxazinobensazolfoereningar
DK244090D0 (da) Kemiske forbindelser
DK150591D0 (da) Kemisk forbindelse
FI940890L (fi) Uusia yhdisteitä
MX9206711A (es) Compuestos quimicos
FI943637L (fi) Aryylialkoksifenoksi-imidatsoliiniyhdisteitä
DK144591D0 (da) Kemisk forbindelse